Insider Trading Summary for U.S. Stocks on October 23, 2024

Top Insider Buys

• Inhibikase Therapeutics Inc. (NASDAQ: IKT)
  Directors made notable purchases:

  • Roberto Bellini: 1,460,000 shares at $1.37 each (~$2,000,200) through BSQUARED CAPITAL INC. He also received options for 60,000 shares at $2.22.
  • Kush Arvind: 145,000 shares at $1.37 each ($198,650).
  • Amit Munshi: 365,000 shares at $1.37 each (~$500,050) through the Amit Munshi Revocable Trust. All received options for 60,000 shares at $2.22.

• Texas Capital Bancshares Inc. (NASDAQ: TCBI)
  Director Robert W. Stallings acquired 20,000 depositary shares of Series B Preferred Stock at $21.28 each (~$425,600). He now owns 84,587 shares directly and additional indirect stakes.

• RDE, Inc. (NASDAQ: GIFT)
  CTO Balazs Wellisch purchased 36,000 shares at prices from $1.45 to $2.95, totaling $53,700, increasing his ownership to 1,040,217 shares.

Top Insider Sells

• Penumbra Inc (NYSE: PEN)
  CEO Adam Elsesser sold 15,000 shares at $202.86 to $206.53, totaling ~$3.07 million under a Rule 10b5-1 plan.

• Carvana Co. (NYSE: CVNA)
  Major shareholder Ernest C. Garcia II sold shares totaling ~$38.6 million at prices between $189.59 and $197.38 under a pre-established plan.

• Zoom Video Communications Inc. (NASDAQ: ZM)
  CEO Eric Yuan sold 71,436 shares of Class A stock at $70.81 to $72.21, totaling ~$5.13 million under a Rule 10b5-1 plan.

• Atlassian Corp (NASDAQ: TEAM)
  Two executives sold:

  • CEO Michael Cannon-Brookes: 7,948 shares at $191.40 to $195.58 (~$1.54 million).
  • Director Scott Farquhar: also sold 7,948 shares in the same range (~$1.54 million).

Conclusion

Investors should monitor insider trading for insights into a company's financial health. Insider buys often signify future confidence, while sells can have varied motivations and should be assessed carefully as part of broader investment analysis.

This article was generated with the support of AI and reviewed by an editor. For more information, see our T&C.